Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Turesson

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon therapy during the plateau phase of multiple myeloma: an update of the Swedish studyJ Westin, A Cortelezzi, M Hjorth, et al.
International Journal of Cancer|December 8, 1998
Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation TherapyN G Burnet, J Johansen, I Turesson, et al.
British Journal of Haematology|March 1, 1995
Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study. Cooperative Study GroupJ Westin, S Rödjer, I Turesson, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patternsI Turesson, N Sandberg, C Mercke, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2000
A microradiographic investigation of cancellous bone healing after irradiation and hyperbaric oxygenation: a rabbit studyA A Johnsson, M Jacobsson, G Granström, et al.
International Journal of Radiation Biology|November 1, 1989
Fractionation parameters for human tissues and tumorsH D Thames, S M Bentzen, I Turesson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1990
Time-dose factors in radiotherapy: a review of the human dataH D Thames, S M Bentzen, I Turesson, et al.
Stroke|November 1, 1982
Is occult atrial disorder a frequent cause of non-hemorrhagic stroke? Long-term ECG in 86 patientsN J Abdon, O Zettervall, J Carlson, et al.
Lancet (London, England)|June 27, 1992
Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivityN G Burnet, J Nyman, I Turesson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1994
The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedulesN G Burnet, J Nyman, I Turesson, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Interferon therapy during the plateau phase of multiple myeloma: an update of the Swedish studyJ Westin, A Cortelezzi, M Hjorth, et al.
International Journal of Cancer|December 8, 1998
Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation TherapyN G Burnet, J Johansen, I Turesson, et al.
British Journal of Haematology|March 1, 1995
Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study. Cooperative Study GroupJ Westin, S Rödjer, I Turesson, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patternsI Turesson, N Sandberg, C Mercke, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2000
A microradiographic investigation of cancellous bone healing after irradiation and hyperbaric oxygenation: a rabbit studyA A Johnsson, M Jacobsson, G Granström, et al.
International Journal of Radiation Biology|November 1, 1989
Fractionation parameters for human tissues and tumorsH D Thames, S M Bentzen, I Turesson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1990
Time-dose factors in radiotherapy: a review of the human dataH D Thames, S M Bentzen, I Turesson, et al.
Stroke|November 1, 1982
Is occult atrial disorder a frequent cause of non-hemorrhagic stroke? Long-term ECG in 86 patientsN J Abdon, O Zettervall, J Carlson, et al.
Lancet (London, England)|June 27, 1992
Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivityN G Burnet, J Nyman, I Turesson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 1, 1994
The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedulesN G Burnet, J Nyman, I Turesson, et al.
Pageof 12